（吉隆坡24日讯）葛兰素史克制药有限公司（GSK）宣布，Arexvy 疫苗（MAL24086007ARZ）已在马来西亚获得批准用于治疗呼吸道合胞病毒（RSV）。RSV是一种常见的呼吸道病毒，可引起下呼吸道疾病（LRTD）和老年人肺炎等严重的临床影响。马拉工艺大学苏丹阿都拉教学医院副院长兼呼吸内科顾问阿末依祖亚努丁表示，RSV可能会造成严重影响，尤其是对患有哮喘、慢性阻塞性肺病（COPD）和慢性心力 ...

New RSV jab could prevent thousands of older people dying, researchers say - Elderly people and babies are at risk of severe ...

The 2024-25 respiratory season is underway and for the first time, New Brunswick will offer some seniors immunization against ...

Health care providers say Iowans should get their COVID-19, influenza and RSV vaccines in September or October ...

Reformulated flu and COVID-19 shots are available to Oregonians starting this month. And an RSV vaccine — developed only last ...

Results looking at the first season of RSV use shows that it is 75% effective at preventing RSV-associated hospitalizations ...

意大利《共和国报》报道，气候变化使得秋季变得越来越温暖，这会让病毒传播更加活跃。

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

That means the fall respiratory virus season is back too. It's the time of year where doctors see increased levels of ...

The trial testing the immune response of co-administration of GSK's blockbuster vaccines, Shingrix and Arexvy, in adults over ...

The respiratory syncytial virus (RSV) space may have filled up over the past year, but that isn’t deterring Vicebio or its ...

THAT MEANS THE FALL RESPIRATORY VIRUS SEASON IS BACK, TOO. IT’S THE TIME OF YEAR WHEN DOCTORS SEE INCREASED LEVELS OF ...